Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Tolerance to arsenic trioxide combined with all-trans-retinoic acid in children with acute promyelocytic leukaemia in France.

Garcia Spezza E, Brethon B, Petit A, Mazingue F, Gandemer V, Boissel N, Carausu L, Reguerre Y, Leverger G, Ducassou S.

Br J Haematol. 2020 Jan;188(1):170-173. doi: 10.1111/bjh.16364. Epub 2019 Dec 6. No abstract available.

PMID:
31808943
2.

Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study.

Pieters R, De Lorenzo P, Ancliffe P, Aversa LA, Brethon B, Biondi A, Campbell M, Escherich G, Ferster A, Gardner RA, Kotecha RS, Lausen B, Li CK, Locatelli F, Attarbaschi A, Peters C, Rubnitz JE, Silverman LB, Stary J, Szczepanski T, Vora A, Schrappe M, Valsecchi MG.

J Clin Oncol. 2019 Sep 1;37(25):2246-2256. doi: 10.1200/JCO.19.00261. Epub 2019 Jul 8.

PMID:
31283407
3.

Durable remissions in TCF3-HLF positive acute lymphoblastic leukemia with blinatumomab and stem cell transplantation.

Mouttet B, Vinti L, Ancliff P, Bodmer N, Brethon B, Cario G, Chen-Santel C, Elitzur S, Hazar V, Kunz J, Möricke A, Stein J, Vora A, Yaman Y, Schrappe M, Anak S, Baruche A, Locatelli F, von Stackelberg A, Stanulla M, Bourquin JP.

Haematologica. 2019 Jun;104(6):e244-e247. doi: 10.3324/haematol.2018.210104. Epub 2019 Feb 14. No abstract available.

4.

Parents' and children's comprehension and decision in a paediatric early phase oncology trial: a prospective study.

Béranger A, Bouazza N, de Haut de Sigy A, Foubert-Wenc AC, Davous D, Aerts I, Geoerger B, Auvrignon A, Brethon B, Leblond P, Corradini N, André N, Martinez H, Dupont JK, Doz F, Chappuy H.

Arch Dis Child. 2019 Oct;104(10):947-952. doi: 10.1136/archdischild-2018-315237. Epub 2018 Nov 24.

PMID:
30472665
5.

A phase 1/2, open-label, dose-escalation study of midostaurin in children with relapsed or refractory acute leukaemia.

Zwaan CM, Söderhäll S, Brethon B, Luciani M, Rizzari C, Stam RW, Besse E, Dutreix C, Fagioli F, Ho PA, Dufour C, Pieters R.

Br J Haematol. 2019 May;185(3):623-627. doi: 10.1111/bjh.15593. Epub 2018 Sep 11. No abstract available.

PMID:
30203832
6.

Clofarabine, high-dose cytarabine and liposomal daunorubicin in pediatric relapsed/refractory acute myeloid leukemia: a phase IB study.

van Eijkelenburg NKA, Rasche M, Ghazaly E, Dworzak MN, Klingebiel T, Rossig C, Leverger G, Stary J, De Bont ESJM, Chitu DA, Bertrand Y, Brethon B, Strahm B, van der Sluis IM, Kaspers GJL, Reinhardt D, Zwaan CM.

Haematologica. 2018 Sep;103(9):1484-1492. doi: 10.3324/haematol.2017.187153. Epub 2018 May 17.

7.

CD19-negative relapse of pediatric B-cell precursor acute lymphoblastic leukemia following blinatumomab treatment.

Mejstríková E, Hrusak O, Borowitz MJ, Whitlock JA, Brethon B, Trippett TM, Zugmaier G, Gore L, von Stackelberg A, Locatelli F.

Blood Cancer J. 2017 Dec 20;7(12):659. doi: 10.1038/s41408-017-0023-x. No abstract available.

8.

Oncogenetic mutations combined with MRD improve outcome prediction in pediatric T-cell acute lymphoblastic leukemia.

Petit A, Trinquand A, Chevret S, Ballerini P, Cayuela JM, Grardel N, Touzart A, Brethon B, Lapillonne H, Schmitt C, Thouvenin S, Michel G, Preudhomme C, Soulier J, Landman-Parker J, Leverger G, Macintyre E, Baruchel A, Asnafi V; French Acute Lymphoblastic Leukemia Study Group (FRALLE).

Blood. 2018 Jan 18;131(3):289-300. doi: 10.1182/blood-2017-04-778829. Epub 2017 Oct 19.

PMID:
29051182
9.

Appendicitis in a Neutropenic Patient: A Multicentric Retrospective Study.

Scarpa AA, Hery G, Petit A, Brethon B, Jimenez I, Gandemer V, Abbou S, Haouy S, Breaud J, Poiree M.

J Pediatr Hematol Oncol. 2017 Jul;39(5):365-369. doi: 10.1097/MPH.0000000000000834.

PMID:
28486259
10.

Late effects in survivors of infantile acute leukemia: a study of the L.E.A program.

Gandemer V, Bonneau J, Oudin C, Berbis J, Bertrand Y, Tabone MD, Ducassou S, Chastagner P, Brethon B, Dalle JH, Thouvenin S, Poiree M, Plantaz D, Kanold J, Sirvent N, Lutz P, Hamidou Z, Baruchel A, Leverger G, Auquier P, Michel G.

Blood Cancer J. 2017 Jan 20;7(1):e518. doi: 10.1038/bcj.2016.129. No abstract available.

11.

Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia.

von Stackelberg A, Locatelli F, Zugmaier G, Handgretinger R, Trippett TM, Rizzari C, Bader P, O'Brien MM, Brethon B, Bhojwani D, Schlegel PG, Borkhardt A, Rheingold SR, Cooper TM, Zwaan CM, Barnette P, Messina C, Michel G, DuBois SG, Hu K, Zhu M, Whitlock JA, Gore L.

J Clin Oncol. 2016 Dec 20;34(36):4381-4389. Epub 2016 Oct 31.

PMID:
27998223
12.

[Infant acute leukemia].

Brethon B, Cavé H, Fahd M, Baruchel A.

Bull Cancer. 2016 Mar;103(3):299-311. doi: 10.1016/j.bulcan.2015.11.009. Epub 2016 Jan 27. French.

PMID:
26826739
13.

Impact of therapy in a cohort of unselected children with Down Syndrome-associated Acute Lymphoblastic Leukaemia.

Derouet A, Petit A, Baruchel A, Clavel J, Brethon B, Bertrand Y, Lutz P, Nacka F, Ducassou S.

Br J Haematol. 2016 Sep;174(6):983-5. doi: 10.1111/bjh.13817. Epub 2015 Oct 12. No abstract available.

PMID:
26457881
14.

A Phase I Study of Clofarabine With Multiagent Chemotherapy in Childhood High Risk Relapse of Acute Lymphoblastic Leukemia (VANDEVOL Study of the French SFCE Acute Leukemia Committee).

Nelken B, Cave H, Leverger G, Galambrun C, Plat G, Schmitt C, Thomas C, Vérité C, Brethon B, Gandemer V, Bertrand Y, Baruchel A, Rohrlich P.

Pediatr Blood Cancer. 2016 Feb;63(2):270-5. doi: 10.1002/pbc.25751. Epub 2015 Sep 16.

PMID:
26376115
15.

Activating mutations in RRAS underlie a phenotype within the RASopathy spectrum and contribute to leukaemogenesis.

Flex E, Jaiswal M, Pantaleoni F, Martinelli S, Strullu M, Fansa EK, Caye A, De Luca A, Lepri F, Dvorsky R, Pannone L, Paolacci S, Zhang SC, Fodale V, Bocchinfuso G, Rossi C, Burkitt-Wright EM, Farrotti A, Stellacci E, Cecchetti S, Ferese R, Bottero L, Castro S, Fenneteau O, Brethon B, Sanchez M, Roberts AE, Yntema HG, Van Der Burgt I, Cianci P, Bondeson ML, Cristina Digilio M, Zampino G, Kerr B, Aoki Y, Loh ML, Palleschi A, Di Schiavi E, Carè A, Selicorni A, Dallapiccola B, Cirstea IC, Stella L, Zenker M, Gelb BD, Cavé H, Ahmadian MR, Tartaglia M.

Hum Mol Genet. 2014 Aug 15;23(16):4315-27. doi: 10.1093/hmg/ddu148. Epub 2014 Apr 4.

16.

Invasive infections due to Candida norvegensis and Candida inconspicua: report of 12 cases and review of the literature.

Guitard J, Angoulvant A, Letscher-Bru V, L'Ollivier C, Cornet M, Dalle F, Grenouillet F, Lacroix C, Vekhoff A, Maury E, Caillot D, Charles PE, Pili-Floury S, Herbrecht R, Raffoux E, Brethon B, Hennequin C.

Med Mycol. 2013 Nov;51(8):795-9. doi: 10.3109/13693786.2013.807444. Epub 2013 Jul 16. Review.

PMID:
23855412
17.

Indications and outcomes of antifungal therapy in French patients with haematological conditions or recipients of haematopoietic stem cell transplantation.

Herbrecht R, Caillot D, Cordonnier C, Auvrignon A, Thiébaut A, Brethon B, Michallet M, Mahlaoui N, Bertrand Y, Preziosi P, Ruiz F, Gorin NC, Gangneux JP.

J Antimicrob Chemother. 2012 Nov;67(11):2731-8. doi: 10.1093/jac/dks266. Epub 2012 Jul 31.

PMID:
22850692
18.

Prospective evaluation of clinical and biological markers to predict the outcome of invasive pulmonary aspergillosis in hematological patients.

Bergeron A, Porcher R, Menotti J, Poirot JL, Chagnon K, Vekhoff A, Cornet M, Isnard F, Raffoux E, Brethon B, Lacroix C, Touratier S, Latgé JP, Bouges-Michel C, Tazi A, Derouin F, Ribaud P, Sulahian A.

J Clin Microbiol. 2012 Mar;50(3):823-30. doi: 10.1128/JCM.00750-11. Epub 2011 Dec 14.

19.

The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies.

Bergeron A, Porcher R, Sulahian A, de Bazelaire C, Chagnon K, Raffoux E, Vekhoff A, Cornet M, Isnard F, Brethon B, Lacroix C, Poirot JL, Bouges C, Derouin F, Tazi A, Ribaud P.

Blood. 2012 Feb 23;119(8):1831-7; quiz 1956. doi: 10.1182/blood-2011-04-351601. Epub 2011 Oct 18.

PMID:
22010103
20.

Parental comprehension and satisfaction in informed consent in paediatric clinical trials: a prospective study on childhood leukaemia.

Chappuy H, Baruchel A, Leverger G, Oudot C, Brethon B, Haouy S, Auvrignon A, Davous D, Doz F, Tréluyer JM.

Arch Dis Child. 2010 Oct;95(10):800-4. doi: 10.1136/adc.2009.180695. Epub 2010 Jun 15.

PMID:
20551191
21.

[Acute lymphoblastic leukemias in children, care and long term prognosis].

Brethon B.

Soins Pediatr Pueric. 2009 Dec;(251):19-20. French. No abstract available.

PMID:
19994709
22.

Diagnosis of Fanconi anemia in patients with bone marrow failure.

Pinto FO, Leblanc T, Chamousset D, Le Roux G, Brethon B, Cassinat B, Larghero J, de Villartay JP, Stoppa-Lyonnet D, Baruchel A, Socié G, Gluckman E, Soulier J.

Haematologica. 2009 Apr;94(4):487-95. doi: 10.3324/haematol.13592. Epub 2009 Mar 10.

23.

Large scale transient 5-HT3 receptor production with the Semliki Forest Virus Expression System.

Blasey HD, Brethon B, Hovius R, Vogel H H, Tairi AP, Lundström K, Rey L, Bernard AR.

Cytotechnology. 2000 Mar;32(3):199-208. doi: 10.1023/A:1008192709549.

24.

Efficacy of fractionated gemtuzumab ozogamicin combined with cytarabine in advanced childhood myeloid leukaemia.

Brethon B, Yakouben K, Oudot C, Boutard P, Bruno B, Jérome C, Nelken B, de Lumley L, Bertrand Y, Dalle JH, Chevret S, Leblanc T, Baruchel A.

Br J Haematol. 2008 Nov;143(4):541-7. doi: 10.1111/j.1365-2141.2008.07370.x. Epub 2008 Aug 28.

PMID:
18759760
25.

Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia.

Porkka K, Koskenvesa P, Lundán T, Rimpiläinen J, Mustjoki S, Smykla R, Wild R, Luo R, Arnan M, Brethon B, Eccersley L, Hjorth-Hansen H, Höglund M, Klamova H, Knutsen H, Parikh S, Raffoux E, Gruber F, Brito-Babapulle F, Dombret H, Duarte RF, Elonen E, Paquette R, Zwaan CM, Lee FY.

Blood. 2008 Aug 15;112(4):1005-12. doi: 10.1182/blood-2008-02-140665. Epub 2008 May 13.

PMID:
18477770
26.

Invasive pulmonary infection due to Trichoderma longibrachiatum mimicking invasive Aspergillosis in a neutropenic patient successfully treated with voriconazole combined with caspofungin.

Alanio A, Brethon B, Feuilhade de Chauvin M, de Kerviler E, Leblanc T, Lacroix C, Baruchel A, Menotti J.

Clin Infect Dis. 2008 May 15;46(10):e116-8. doi: 10.1086/587750.

PMID:
18419477
27.

SFCE (Société Française de Lutte contre les Cancers et Leucémies de l'Enfant et de l'Adolescent) recommendations for the management of tumor lysis syndrome (TLS) with rasburicase: an observational survey.

Bertrand Y, Mechinaud F, Brethon B, Mialou V, Auvrignon A, Nelken B, Notz-Carrère A, Plantaz D, Patte C, Urbieta M, Baruchel A, Leverger G; SFCE.

J Pediatr Hematol Oncol. 2008 Apr;30(4):267-71. doi: 10.1097/MPH.0b013e318162bd41.

PMID:
18391694
28.

Image-guided core-needle biopsy of peripheral lymph nodes allows the diagnosis of lymphomas.

de Kerviler E, de Bazelaire C, Mounier N, Mathieu O, Brethon B, Brière J, Marolleau JP, Brice P, Gisselbrecht C, Frija J.

Eur Radiol. 2007 Mar;17(3):843-9. Epub 2006 Sep 26.

PMID:
17021708
29.

Efficacy and tolerability of gemtuzumab ozogamicin (anti-CD33 monoclonal antibody, CMA-676, Mylotarg) in children with relapsed/refractory myeloid leukemia.

Brethon B, Auvrignon A, Galambrun C, Yakouben K, Leblanc T, Bertrand Y, Leverger G, Baruchel A.

BMC Cancer. 2006 Jun 28;6:172.

30.

Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML).

Boissel N, Leroy H, Brethon B, Philippe N, de Botton S, Auvrignon A, Raffoux E, Leblanc T, Thomas X, Hermine O, Quesnel B, Baruchel A, Leverger G, Dombret H, Preudhomme C; Acute Leukemia French Association (ALFA); Leucémies Aiguës Myéloblastiques de l'Enfant (LAME) Cooperative Groups.

Leukemia. 2006 Jun;20(6):965-70.

PMID:
16598313
31.

Molecular response in two children with relapsed acute myeloid leukemia treated with a combination of gemtuzumab ozogamicin and cytarabine.

Brethon B, Auvrignon A, Cayuela JM, Lapillonne H, Leverger G, Baruchel A.

Haematologica. 2006 Mar;91(3):419-21.

32.

Occurrence and kinetics of false-positive Aspergillus galactomannan test results following treatment with beta-lactam antibiotics in patients with hematological disorders.

Aubry A, Porcher R, Bottero J, Touratier S, Leblanc T, Brethon B, Rousselot P, Raffoux E, Menotti J, Derouin F, Ribaud P, Sulahian A.

J Clin Microbiol. 2006 Feb;44(2):389-94.

33.

Long-term expansion of human functional epidermal precursor cells: promotion of extensive amplification by low TGF-beta1 concentrations.

Fortunel NO, Hatzfeld JA, Rosemary PA, Ferraris C, Monier MN, Haydont V, Longuet J, Brethon B, Lim B, Castiel I, Schmidt R, Hatzfeld A.

J Cell Sci. 2003 Oct 1;116(Pt 19):4043-52.

34.

Treatment of childhood autoimmune haemolytic anaemia with rituximab.

Quartier P, Brethon B, Philippet P, Landman-Parker J, Le Deist F, Fischer A.

Lancet. 2001 Nov 3;358(9292):1511-3.

PMID:
11705566

Supplemental Content

Loading ...
Support Center